ACC017 not checked

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
2 active
4 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Infection, Human Immunodeficiency Virus (2 trials)
Main trialPhase 3
“This study employs a multicenter, randomized, double-blind, double-dummy, active-controlled, parallel-group, non-inferiority design. The trial will be conducted in treatment-naïve adult patients with HIV-1, using Dolutegravir Sodium Tablets as the control, to demonstrate the efficacy and safety of the core investigational drug ACC017 combined with FTC/TAF Tablets (II) compared to Dolutegravir Sodium combined with FTC/TAF Tablets (II) in treating treatment-naïve adult HIV-1 patients. After initial screening eligibility is confirmed, participants will return to the clinic on Day 1 (D1) for…”In the company’s words, NCT07711223 on ClinicalTrials.gov

Other drugs for Infection, Human Immunodeficiency Virus

All 602 drugs for Infection, Human Immunodeficiency Virus

Coming up2

Changes2

Last 90 days

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 31 Aug 2028 Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)
Phase 1/2Active, not recruiting 30 Jun 2027 Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations
Phase 1/2Completed 28 Apr 2025 Phase Ib/IIa Clinical Study of ACC017 Tablets
Phase 1Completed 20 May 2024 Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow ACC017

Following is part of Solo: you see every change to ACC017 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in